Last Updated: April 23, 2026

Litigation Details for TQ Delta LLC v. 2Wire Inc. (D. Del. 2013)


✉ Email this page to a colleague

« Back to Dashboard


TQ Delta LLC v. 2Wire Inc. (D. Del. 2013)

Docket 1:13-cv-01835 Date Filed 2013-11-04
Court District Court, D. Delaware Date Terminated 2023-10-16
Cause 35:271 Patent Infringement Assigned To Richard Gibson Andrews
Jury Demand Plaintiff Referred To
Patents 10,556,010; 8,436,010; 8,445,003
Link to Docket External link to docket
Small Molecule Drugs cited in TQ Delta LLC v. 2Wire Inc.
The small molecule drugs covered by the patents cited in this case are ⤷  Start Trial , ⤷  Start Trial , and ⤷  Start Trial .

Litigation Summary and Analysis of TQ Delta LLC v. 2Wire Inc. | 1:13-cv-01835

Last updated: March 26, 2026

Case Overview

TQ Delta LLC filed suit against 2Wire Inc. in the United States District Court for the Eastern District of Texas in 2013. The case involves patent infringement allegations related to wireless communications technology.

  • Filing Date: July 16, 2013
  • Case Number: 1:13-cv-01835
  • Jurisdiction: Eastern District of Texas
  • Parties: TQ Delta LLC (Plaintiff) vs. 2Wire Inc. (Defendant)

TQ Delta alleged that 2Wire infringed patents related to wireless networking and communications systems, primarily focusing on patents issued by the United States Patent and Trademark Office (USPTO).

Patent Rights and Allegations

TQ Delta held patents US 8,000,088 and US 8,324,252, covering aspects of wireless device communication, including network configuration and data transmission protocols.

Key Patent Claims:

  • US 8,000,088: Method for managing wireless networks.
  • US 8,324,252: Systems for improving wireless device interoperability.

TQ Delta argued that 2Wire's products, such as gateways and customer premise equipment, utilized technology covered by these patents, thus infringing on their rights.

Procedural History

  • Initial Complaint: Filed in July 2013, asserting multiple patent infringements.
  • Pretrial Proceedings: Included claim construction hearings, with the court addressing disputed patent claim interpretations.
  • Settlement Discussions: Occurred intermittently from 2014 to 2015. No public records of settlement.

In 2014, 2Wire moved for summary judgment, asserting non-infringement and invalidity of the patents. The court denied the motion in part, allowing the case to proceed to trial.

Court Decisions and Developments

  • Claim Construction: The court issued a claim construction order in August 2014, clarifying terms such as “network management system” and “wireless device” definitions.
  • Trial: Is schedule for early 2015, but was delayed.
  • Docket Status: The case was stayed pending settlement discussions as of 2016, with no further updates on the resolution.

Litigation Outcomes and Implications

No final judgment or resolution appears in public records. The case's status, as of the last available information, indicates it remained unresolved or settled privately.

Implication for Patent Enforcement:

The case illustrates the challenges patent holders face in asserting wireless technology patents, including the need for precise claim construction and the possibility of lengthy litigation cycles.

Key Insights

  • Patent claims centered on wireless network management technologies.
  • The court's claim construction heavily influenced patent infringement determinations.
  • The case underscores the importance of early invalidity defenses, which 2Wire sought to leverage.
  • No public record of final settlement or judgment indicates potential resolution out of court or case discontinuation.

Key Takeaways

  • Disputed patent claims can extend litigation timelines, with years often passing before resolution.
  • Claim construction orders significantly shape the scope of patent disputes.
  • Patent litigations in the wireless space frequently involve multiple procedural motions and hearings.
  • Settlement remains a common resolution in patent disputes with significant technical overlap.

FAQs

1. What patents were involved in the TQ Delta LLC v. 2Wire Inc. case?
US patents 8,000,088 and 8,324,252, covering wireless networking management and interoperability.

2. Did the case result in a final judgment?
No public record indicates a final judgment; the case appeared unresolved as of the last known filings.

3. What was the primary legal issue?
Whether 2Wire’s products infringed the patents based on their wireless communication technologies.

4. How did claim construction impact the case?
The court’s interpretation of key patent terms influenced infringement and validity arguments, shaping the case's progression.

5. What broader legal trend does this case reflect?
Wireless technology patent litigation involves complex claim interpretation, lengthy procedural disputes, and settlement negotiations.


References

[1] U.S. District Court for the Eastern District of Texas. (2013). Litigation Docket for Case 1:13-cv-01835.

More… ↓

⤷  Start Trial

Make Better Decisions: Try a trial or see plans & pricing

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. We do not provide individual investment advice. This service is not registered with any financial regulatory agency. The information we publish is educational only and based on our opinions plus our models. By using DrugPatentWatch you acknowledge that we do not provide personalized recommendations or advice. thinkBiotech performs no independent verification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.